J. L. Ferrara, J. E. Levine, P. Reddy, and E. Holler, Graft-versus-host disease, Lancet, vol.373, issue.9674, pp.1550-61, 2009.

E. Hatzimichael and M. Tuthill, Hematopoietic stem cell transplantation, Stem Cells Cloning, vol.3, pp.105-122, 2010.

M. Koyama and G. R. Hill, Alloantigen presentation and graft-versus-host disease: fuel for the fire, Blood, vol.127, issue.24, 2016.
DOI : 10.1182/blood-2016-02-697250

URL : http://www.bloodjournal.org/content/127/24/2963.full.pdf

H. J. Kolb, Graft-versus-leukemia effects of transplantation and donor lymphocytes, Blood, vol.112, issue.12, pp.4371-83, 2008.

J. Storek, M. Geddes, F. Khan, B. Huard, C. Helg et al., Reconstitution of the immune system after hematopoietic stem cell transplantation in humans, Semin Immunopathol, vol.30, issue.4, pp.425-462, 2008.

M. L. Macmillan, T. E. Defor, and D. J. Weisdorf, The best endpoint for acute GVHD treatment trials, Blood, issue.26, pp.5412-5419, 2010.

L. Qian, Z. Wu, and J. Shen, Advances in the treatment of acute graft-versus-host disease, J Cell Mol Med, vol.17, issue.8, pp.966-75, 2013.

S. Servais, Y. Beguin, L. Delens, G. Ehx, G. Fransolet et al., Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, Expert Opin Investig Drugs, vol.25, issue.8, pp.957-72, 2016.
DOI : 10.1080/13543784.2016.1182498

URL : https://orbi.uliege.be/bitstream/2268/196156/4/368.pdf

S. Matthes-martin, U. Potschger, K. Bergmann, F. Frommlet, W. Brannath et al., Risk-adjusted outcome measurement in pediatric allogeneic stem cell transplantation, Biol Blood Marrow Transplant, vol.14, issue.3, pp.335-378, 2008.
DOI : 10.1016/j.bbmt.2007.12.487

URL : https://doi.org/10.1016/j.bbmt.2007.12.487

I. S. Moiseev, O. V. Pirogova, A. L. Alyanski, E. V. Babenko, T. L. Gindina et al., Graft-versus-host disease prophylaxis in unrelated peripheral blood stem cell transplantation with post-transplantation cyclophosphamide, tacrolimus, and mycophenolate mofetil, Biol Blood Marrow Transplant, vol.22, issue.6, pp.1037-1079, 2016.

A. S. Al-homsi, T. S. Roy, K. Cole, Y. Feng, and U. Duffner, Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease, Biol Blood Marrow Transplant, vol.21, issue.4, pp.604-615, 2015.

Y. Reisner, D. Hagin, and M. F. Martelli, Haploidentical hematopoietic transplantation: current status and future perspectives, Blood, vol.118, issue.23, pp.6006-6023, 2011.
DOI : 10.1182/blood-2011-07-338822

URL : http://www.bloodjournal.org/content/118/23/6006.full.pdf

N. Poirier, A. M. Azimzadeh, T. Zhang, N. Dilek, C. Mary et al., Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation, Sci Transl Med, vol.2, issue.17, pp.17-17, 2010.
DOI : 10.1126/scitranslmed.3000116

URL : http://europepmc.org/articles/pmc2860737?pdf=render

D. T. Koura, J. T. Horan, A. A. Langston, M. Qayed, A. Mehta et al., In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial, Biol Blood Marrow Transplant, vol.19, issue.11, pp.1638-1687, 2013.

N. Poirier, C. Mary, N. Dilek, J. Hervouet, D. Minault et al., Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody, Am J Transplant, vol.12, issue.10, pp.2630-2670, 2012.

N. Dilek, N. Poirier, P. Hulin, F. Coulon, C. Mary et al., CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells, PLoS One, vol.28, issue.12, p.83139, 2013.

N. Poirier, C. Mary, L. Bas-bernardet, S. Daguin, V. Belarif et al., Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28, MAbs, vol.6, issue.3, pp.697-707, 2014.

P. H. Papotto, E. B. Marengo, L. R. Sardinha, K. I. Carvalho, A. E. De-carvalho et al., Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-gamma production, PLoS One, vol.12, issue.3, p.171822, 2017.
DOI : 10.1371/journal.pone.0171822

URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171822&type=printable

N. Poirier, N. Dilek, C. Mary, S. Ville, F. Coulon et al., FR104, an antagonist anti-CD28 monovalent Fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft, Am J Transplant, vol.15, issue.1, pp.88-100, 2015.
DOI : 10.1111/ajt.12964

URL : https://hal.archives-ouvertes.fr/inserm-02148443

S. Ville, N. Poirier, J. Branchereau, V. Charpy, S. Pengam et al., Anti-CD28 antibody and belatacept exert differential effects on mechanisms of renal allograft rejection, J Am Soc Nephrol, vol.27, issue.12, pp.3577-88, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02150329

K. G. Haanstra, K. Dijkman, N. Bashir, J. Bauer, C. Mary et al., Selective blockade of CD28-mediated T cell costimulation protects rhesus monkeys against acute fatal experimental autoimmune encephalomyelitis, J Immunol, vol.194, issue.4, pp.1454-66, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02148517

M. P. Vierboom, E. Breedveld, Y. S. Kap, C. Mary, N. Poirier et al., Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis, Clin Exp Immunol, vol.183, issue.3, pp.405-423, 2016.

N. Poirier, G. Blancho, M. Hiance, M. C. Van-assche, T. Lempoels et al., First-in-human study in healthy subjects with FR104, a pegylated monoclonal antibody fragment antagonist of CD28, J Immunol, vol.197, issue.12, pp.4593-602, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02150993

M. Lanzinger, B. Jurgens, U. Hainz, B. Dillinger, J. Raberger et al., Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase, Eur J Immunol, vol.42, issue.5, pp.1117-1145, 2012.

N. Poirier, M. Chevalier, C. Mary, J. Hervouet, D. Minault et al., Selective CD28 antagonist blunts memory immune responses and promotes long-term control of skin inflammation in nonhuman primates, J Immunol, vol.196, issue.1, pp.274-83, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02150299

C. S. Carlson, R. O. Emerson, A. M. Sherwood, C. Desmarais, M. W. Chung et al., Using synthetic templates to design an unbiased multiplex PCR assay, Nat Commun, vol.4, p.2680, 2013.

C. A. Bauerlein, S. S. Riedel, J. Baker, C. Brede, A. L. Garrote et al., A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model, BMC Med, vol.11, p.134, 2013.

E. Mayer, M. Holzl, S. Ahmadi, B. Dillinger, N. Pilat et al., CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk, Int Immunopharmacol, vol.15, issue.3, pp.638-683, 2013.

T. Zhang, S. Fresnay, E. Welty, N. Sangrampurkar, E. Rybak et al., Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner, Am J Transplant, vol.11, issue.8, pp.1599-609, 2011.

J. Proff, C. Walterskirchen, C. Brey, R. Geyeregger, F. Full et al., Cytomegalovirus-infected cells resist T cell mediated killing in an HLArecognition independent manner, Front Microbiol, vol.7, p.844, 2016.

K. R. Cooke, L. Kobzik, T. R. Martin, J. Brewer, J. Delmonte et al., An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin, Blood, vol.88, issue.8, pp.3230-3239, 1996.

M. C. Hogenes, S. Van-dorp, J. Van-kuik, F. R. Monteiro, N. Ter-hoeve et al., Histological assessment of the sclerotic graft-versus-host response in the humanized RAG2-/-gammac-/-mouse model, Biol Blood Marrow Transplant, vol.18, issue.7, pp.1023-1058, 2012.

P. Jin, T. H. Han, J. Ren, S. Saunders, E. Wang et al., Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies, J Transl Med, vol.8, p.4, 2010.

M. Croft, L. M. Bradley, and S. L. Swain, Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells, J Immunol, vol.152, issue.6, pp.2675-85, 1994.

M. O. Brook, K. J. Wood, and N. D. Jones, The impact of memory T cells on rejection and the induction of tolerance, Transplantation, vol.82, issue.1, pp.1-9, 2006.

A. Valujskikh, B. Pantenburg, and P. S. Heeger, Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice, Am J Transplant, vol.2, issue.6, pp.501-510, 2002.

Y. Zhai, L. Meng, F. Gao, R. W. Busuttil, and J. W. Kupiec-weglinski, Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients, J Immunol, vol.169, issue.8, pp.4667-73, 2002.

B. Beverly, S. M. Kang, M. J. Lenardo, and R. H. Schwartz, Reversal of in vitro T cell clonal anergy by IL-2 stimulation, Int Immunol, vol.4, issue.6, pp.661-71, 1992.

E. Clementi, E. Bucci, G. Citterio, G. Landonio, G. Consogno et al., Reversible anergy in circulating lymphocytes of cancer patients during interleukin-2 therapy, Cancer Immunol Immunother, vol.39, issue.3, pp.167-71, 1994.

C. Macedo, E. A. Orkis, I. Popescu, B. D. Elinoff, A. Zeevi et al., Contribution of naive and memory T-cell populations to the human alloimmune response, Am J Transplant, vol.9, issue.9, pp.2057-66, 2009.

S. Hou, L. Hyland, K. W. Ryan, A. Portner, and P. C. Doherty, Virus-specific CD8+

, T-cell memory determined by clonal burst size, Nature, vol.369, issue.6482, pp.652-656, 1994.

G. J. Freeman, A. J. Long, Y. Iwai, K. Bourque, T. Chernova et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation, J Exp Med, vol.192, issue.7, pp.1027-1061, 2000.

Y. Latchman, C. R. Wood, T. Chernova, D. Chaudhary, M. Borde et al., PD-L2 is a second ligand for PD-1 and inhibits T cell activation, Nat Immunol, vol.2, issue.3, pp.261-269, 2001.

F. Wei, S. Zhong, Z. Ma, H. Kong, A. Medvec et al., Strength of PD-1 signaling differentially affects T-cell effector functions, Proc Natl Acad Sci U S A, vol.110, issue.27, pp.2480-2489, 2013.

J. Duraiswamy, K. M. Kaluza, G. J. Freeman, and G. Coukos, Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors, Cancer Res, vol.73, issue.12, pp.3591-603, 2013.

W. A. Teft, T. A. Chau, and J. Madrenas, Structure-function analysis of the CTLA-4 interaction with PP2A, BMC Immunol, vol.10, p.23, 2009.

Y. C. Kuo, K. Y. Huang, C. H. Yang, Y. S. Yang, W. Y. Lee et al., Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt, J Biol Chem, vol.283, issue.4, pp.1882-92, 2008.

T. Gao, F. Furnari, and A. C. Newton, PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth, Mol Cell, vol.18, issue.1, pp.13-24, 2005.

K. A. Marr, Fungal infections in hematopoietic stem cell transplant recipients, Med Mycol, vol.46, issue.4, pp.293-302, 2008.

J. M. Shi, X. Y. Pei, Y. Luo, Y. M. Tan, R. X. Tie et al., Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years, J Zhejiang Univ Sci B, vol.16, issue.9, pp.796-804, 2015.

R. O. Emerson, J. M. Mathew, I. M. Konieczna, H. S. Robins, and J. R. Leventhal, Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction culture, PLoS One, vol.9, issue.11, p.111943, 2014.

K. Tamada, H. Tamura, D. Flies, Y. X. Fu, E. Celis et al., Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease, J Clin Invest, vol.109, issue.4, pp.549-57, 2002.

W. D. Shlomchik, Graft-versus-host disease, Nat Rev Immunol, vol.7, issue.5, pp.340-52, 2007.

P. Reddy, R. Negrin, and G. R. Hill, Mouse models of bone marrow transplantation, Biol Blood Marrow Transplant, vol.14, issue.1, pp.129-164, 2008.

M. A. Schroeder and J. F. Dipersio, Mouse models of graft-versus-host disease: advances and limitations, Dis Model Mech, vol.4, issue.3, pp.318-351, 2011.

M. K. Jenkins and R. H. Schwartz, Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo, J Exp Med, vol.165, issue.2, pp.302-321, 1987.

D. J. Lenschow, T. L. Walunas, and J. A. Bluestone, CD28/B7 system of T cell costimulation, Annu Rev Immunol, vol.14, pp.233-58, 1996.

P. A. Van-der-merwe, D. L. Bodian, S. Daenke, P. Linsley, and S. J. Davis, CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics, J Exp Med, vol.185, issue.3, pp.393-403, 1997.

E. C. Guinan, V. A. Boussiotis, D. Neuberg, L. L. Brennan, N. Hirano et al., Transplantation of anergic histoincompatible bone marrow allografts, N Engl J Med, vol.340, issue.22, pp.1704-1718, 1999.

J. K. Davies, J. G. Gribben, L. L. Brennan, Y. D. Nadler, L. M. Guinan et al., Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies, Blood, vol.112, issue.6, pp.2232-2273, 2008.

J. K. Davies, C. M. Barbon, A. Voskertchian, L. M. Nadler, and E. C. Guinan, Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation, Cell Transplant, vol.21, issue.9, pp.2047-61, 2012.

M. M. Horowitz, R. P. Gale, P. M. Sondel, J. M. Goldman, J. Kersey et al., Graft-versus-leukemia reactions after bone marrow transplantation, Blood, vol.75, issue.3, pp.555-62, 1990.

D. L. Barber, E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison et al., Restoring function in exhausted CD8 T cells during chronic viral infection, Nature, issue.7077, pp.682-689, 2006.

E. J. Wherry, T cell exhaustion, Nat Immunol, vol.12, issue.6, pp.492-501, 2011.

E. Chuang, T. S. Fisher, R. W. Morgan, M. D. Robbins, J. M. Duerr et al., The CD28 and CTLA-4 receptors associate with the serine/ threonine phosphatase PP2A, Immunity, vol.13, issue.3, pp.31-36, 2000.

M. L. Baroja, L. Vijayakrishnan, E. Bettelli, P. J. Darlington, T. A. Chau et al., Inhibition of CTLA-4 function by the regulatory subunit of serine/ threonine phosphatase 2A, J Immunol, vol.168, issue.10, pp.5070-5078, 2002.

R. V. Parry, J. M. Chemnitz, K. A. Frauwirth, A. R. Lanfranco, I. Braunstein et al., CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms, Mol Cell Biol, vol.25, issue.21, pp.9543-53, 2005.
DOI : 10.1128/mcb.25.21.9543-9553.2005

URL : https://mcb.asm.org/content/25/21/9543.full.pdf

R. Martino, M. Subira, M. Rovira, C. Solano, L. Vazquez et al., Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning, Br J Haematol, vol.116, issue.2, pp.827-860, 2002.